SIX · GIVN.SW
Givaudan S.A.
CHF 3,916.00+CHF 2.00 (+0.05%)
Givaudan S.A.’s quoted price sits in the upper half of its reported 52-week range, 2.47% below the high.
Loading market information…
CPH · NSIS-B.CO · DKK
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 03:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · DKK. Historical prices are not a forecast.
Novozymes A/S’s quoted price sits in the upper half of its reported 52-week range, 3.36% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Novozymes A/S’s forward annual dividend is DKK 4.70 per share, paid semi-annual. The forward yield is 1.01% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Novozymes A/S’s next earnings report is currently expected on Nov 5, 2026, with estimated earnings per share of DKK 5.03. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Novozymes A/S’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global provider of biological solutions, specializing in the development and sale of industrial enzymes, microorganisms, and probiotics. The company's reach extends internationally, serving markets in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Novozymes' diverse portfolio includes protein solutions for the food and beverage sector, alongside a comprehensive suite of cleaning and hygiene offerings for industrial, medical, and household applications, such as drain openers, septic tank treatments, ware washing, and professional laundry. In agriculture, they supply solutions for various crops like corn, cotton, soybeans, and wheat, focusing on bioyield and biocontrol, in addition to animal health and nutrition products and aquaculture systems for warm water species. The company actively supports sustainable industrial processes with contributions to bioenergy (including ethanol, biodiesel, renewable diesel, biogas, and wastewater treatment), biorefining (encompassing fiber modification, bleach boosting, deposit control, starch modification, carbon capture), and applications for textiles and leather. Their extensive range of enzyme solutions, such as lipases, proteases, oxidoreductases, and carbohydrases, are crucial for processes like corn and wheat separation, liquefaction, and saccharification. Furthermore, Novozymes addresses human health with solutions targeting brain, oral, protective, immune, and gastrointestinal well-being, while also engaging in areas like biocatalysis, cell culture, and diagnostics.
Latest available per-share figures in DKK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:48 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 8, 2025 | DKK 3.14+6.44% vs estimate | DKK 8.05B+0.81% vs estimate |
|---|
| Q4 2024 | Feb 26, 2025 | DKK 4.78+23.83% vs estimate | DKK 7.34B-1.19% vs estimate |
|---|
| Q3 2024 | Nov 7, 2024 | DKK 2.68-30.03% vs estimate | DKK 7.61B+1.38% vs estimate |
|---|
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CHF 3,916.00+CHF 2.00 (+0.05%)
Givaudan S.A.’s quoted price sits in the upper half of its reported 52-week range, 2.47% below the high.
€106.40+€0.65 (+0.61%)
dsm-firmenich AG’s quoted price sits in the upper half of its reported 52-week range, 3.14% below the high.
$90.81+$0.15 (+0.17%)
International Flavors & Fragrances Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.06% below the high.
DKK 200.00+DKK 3.60 (+1.83%)
Rockwool A/S’s quoted price sits in the upper half of its reported 52-week range, 14.97% below the high.
$95.59+$1.34 (+1.42%)
Ingredion Incorporated’s quoted price sits in the lower half of its reported 52-week range, 22.59% below the high.
$170.40+$4.10 (+2.47%)
Balchem Corp’s quoted price sits in the upper half of its reported 52-week range, 7.34% below the high.
DKK 464.00+DKK 1.00 (+0.22%)
SP Group A/S’s quoted price sits in the upper half of its reported 52-week range, 6.64% below the high.
